title: t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.
authors.affiliation: Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Candida
authors.initials: C
authors.lastname: Vitale
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Xinyan
authors.initials: X
authors.lastname: Lu
authors.affiliation: Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Balkees
authors.initials: B
authors.lastname: Abderrahman
authors.affiliation: Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Koichi
authors.initials: K
authors.lastname: Takahashi
authors.affiliation: Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Farhad
authors.initials: F
authors.lastname: Ravandi
authors.affiliation: Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Elias
authors.initials: E
authors.lastname: Jabbour
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002885:Chromosomes, Human, Pair 16; D002892:Chromosomes, Human, Pair 22; D002899:Chromosomes, Human, Pair 9; D050660:Core Binding Factors / Q000235:genetics*; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D014178:Translocation, Genetic; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; C581634:BCR-ABL1 fusion protein, human; C095514:CBFbeta-MYH11 fusion protein; D050660:Core Binding Factors; D015514:Oncogene Proteins, Fusion; D016044:Fusion Proteins, bcr-abl